AbbVie Book Value Per Share Growth & History (ABBV)
AbbVie's book value per share was -$1.85 for fiscal 2025.
View full AbbVie company overviewAbbVie annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | -$1.85 | -$3.73 | — |
| 2024 | 2024-12-31 | $1.88 | -$3.98 | −67.89% |
| 2023 | 2023-12-31 | $5.86 | -$3.89 | −39.86% |
| 2022 | 2022-12-31 | $9.75 | $1.04 | +11.94% |
| 2021 | 2021-12-31 | $8.71 | $1.31 | +17.64% |
| 2020 | 2020-12-31 | $7.40 | $12.93 | — |
| 2019 | 2019-12-31 | -$5.52 | $0.20 | — |
| 2018 | 2018-12-31 | -$5.73 | -$8.94 | — |
| 2017 | 2017-12-31 | $3.21 | $0.30 | +10.36% |
| 2016 | 2016-12-31 | $2.91 | $0.46 | +18.79% |
| 2015 | 2015-12-31 | $2.45 | $1.36 | +124.03% |
| 2014 | 2014-12-31 | $1.09 | -$1.73 | −61.35% |
| 2013 | 2013-12-31 | $2.83 | $3.05 | — |
| 2012 | 2012-12-31 | -$0.22 | — | — |
AbbVie quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$3.36 | -$3.25 | — |
| Q1 2026 | 2026-03-31 | -$3.77 | -$4.57 | — |
| Q4 2025 | 2025-12-31 | -$1.85 | -$3.73 | — |
| Q3 2025 | 2025-09-30 | -$1.49 | -$4.91 | — |
| Q2 2025 | 2025-06-30 | -$0.10 | -$3.94 | — |
| Q1 2025 | 2025-03-31 | $0.80 | -$3.73 | −82.27% |
| Q4 2024 | 2024-12-31 | $1.88 | -$3.98 | −67.89% |
| Q3 2024 | 2024-09-30 | $3.41 | -$3.44 | −50.17% |
| Q2 2024 | 2024-06-30 | $3.84 | -$3.45 | −47.36% |
| Q1 2024 | 2024-03-31 | $4.53 | -$2.99 | −39.73% |
| Q4 2023 | 2023-12-31 | $5.86 | -$3.89 | −39.86% |
| Q3 2023 | 2023-09-30 | $6.85 | -$2.19 | −24.26% |
| Q2 2023 | 2023-06-30 | $7.29 | -$1.00 | −12.04% |
| Q1 2023 | 2023-03-31 | $7.52 | -$1.69 | −18.35% |
| Q4 2022 | 2022-12-31 | $9.75 | $1.04 | +11.94% |
| Q3 2022 | 2022-09-30 | $9.04 | $1.38 | +18.00% |
| Q2 2022 | 2022-06-30 | $8.29 | $1.17 | +16.52% |
| Q1 2022 | 2022-03-31 | $9.21 | $1.45 | +18.71% |
| Q4 2021 | 2021-12-31 | $8.71 | $1.31 | +17.64% |
| Q3 2021 | 2021-09-30 | $7.66 | -$0.98 | −11.38% |
| Q2 2021 | 2021-06-30 | $7.11 | -$1.22 | −14.66% |
| Q1 2021 | 2021-03-31 | $7.76 | $12.78 | — |
| Q4 2020 | 2020-12-31 | $7.40 | $12.93 | — |
| Q3 2020 | 2020-09-30 | $8.65 | $14.21 | — |
| Q2 2020 | 2020-06-30 | $8.33 | $14.13 | — |
| Q1 2020 | 2020-03-31 | -$5.02 | $0.27 | — |
| Q4 2019 | 2019-12-31 | -$5.52 | $0.20 | — |
| Q3 2019 | 2019-09-30 | -$5.56 | -$3.62 | — |
| Q2 2019 | 2019-06-30 | -$5.79 | -$3.56 | — |
| Q1 2019 | 2019-03-31 | -$5.29 | -$7.53 | — |
| Q4 2018 | 2018-12-31 | -$5.73 | -$8.94 | — |
| Q3 2018 · Sep 30 | 2018-09-30 | -$1.94 | -$6.13 | — |
| Q2 2018 | 2018-06-30 | -$2.23 | -$6.00 | — |
| Q1 2018 | 2018-03-31 | $2.24 | -$0.90 | −28.70% |
| Q4 2017 | 2017-12-31 | $3.21 | $0.30 | +10.36% |
| Q3 2017 | 2017-09-30 | $4.19 | $0.21 | +5.23% |
| Q2 2017 | 2017-06-30 | $3.77 | $0.31 | +8.84% |
| Q1 2017 | 2017-03-31 | $3.14 | $0.27 | +9.39% |
| Q4 2016 | 2016-12-31 | $2.91 | $0.46 | +18.79% |
| Q3 2016 | 2016-09-30 | $3.98 | $1.01 | +33.81% |
| Q2 2016 | 2016-06-30 | $3.46 | $0.14 | +4.15% |
| Q1 2016 | 2016-03-31 | $2.87 | $2.01 | +232.12% |
| Q4 2015 | 2015-12-31 | $2.45 | $1.36 | +124.03% |
| Q3 2015 | 2015-09-30 | $2.97 | $0.06 | +2.04% |
| Q2 2015 | 2015-06-30 | $3.33 | $0.05 | +1.43% |
| Q1 2015 | 2015-03-31 | $0.86 | -$2.09 | −70.74% |
| Q4 2014 | 2014-12-31 | $1.09 | -$1.73 | −61.35% |
| Q3 2014 | 2014-09-30 | $2.92 | $0.67 | +29.66% |
| Q2 2014 | 2014-06-30 | $3.28 | $1.03 | +46.08% |
| Q1 2014 | 2014-03-31 | $2.95 | $1.09 | +58.21% |
| Q4 2013 | 2013-12-31 | $2.83 | $3.05 | — |
| Q3 2013 | 2013-09-30 | $2.25 | — | — |
| Q2 2013 | 2013-06-30 | $2.24 | — | — |
| Q1 2013 | 2013-03-31 | $1.87 | — | — |
| Q4 2012 | 2012-12-31 | -$0.22 | — | — |
AbbVie book value per share trends
Over the last five fiscal years, AbbVie's book value per share decreased from $7.40 to -$1.85, a change of -$9.25. The latest reported quarter, Q2 2026, shows -$3.36.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review AbbVie source filings ↗Community posts
AbbVie’s menstrual-migraine study meets its primary and all ranked secondary goals
AbbVie ($ABBV) reported positive Phase 3 LUNA results for atogepant in menstrual migraine. The study enrolled 468 women and evaluated treatment across three menstrual cycles. Migraine days during the assessed menstrual period fell by 1.20 d ...